| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/15/1999 | CA2318380A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | CA2317811A1 Treatment of dyskinesias |
| 07/15/1999 | CA2317640A1 Decorated red blood cells |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2317093A1 A2a adenosine receptor agonists |
| 07/15/1999 | CA2317020A1 Non-identical genes and their application in improved molecular adjuvan ts |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316863A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | CA2315265A1 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | CA2282596A1 7-[(piperidin-1-yl)-propoxy]-chromen-4-one derivatives, their preparation and their pharmaceutical use |
| 07/15/1999 | CA2278487A1 Process for preparing carboxamido-4-azasteroids |
| 07/14/1999 | EP0928792A2 Bicyclic(3.1.0)hexanes and related compounds |
| 07/14/1999 | EP0928788A1 Imidazolidin-4-one derivatives useful as anticancer agents |
| 07/14/1999 | EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/14/1999 | EP0928328A1 Methods for culturing cells |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0928290A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 07/14/1999 | EP0928200A2 Therapeutic combinations of rar antagonists and rxr agonists |
| 07/14/1999 | EP0777649B1 N- 2-(pyrrolidinyl-1)-1-phenylethyl]acetamides as kappa receptor agonists |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0553198B1 Regulation of immunoglobulin production by interleukin-9 |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | CN1222524A Carbohydrate derivatives |
| 07/14/1999 | CN1222521A 1,3,8-triaza-spiro [4,5] decan-4-on derivatives |
| 07/14/1999 | CN1222516A Naphth oxazines derivvs., process for their preparation and pharmaceutical compositions containing them |
| 07/14/1999 | CN1222509A New pyrrole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/14/1999 | CN1222355A Ginseng royal jelly without delaminating deposition and its preparation |
| 07/14/1999 | CN1044116C Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action and use thereof |
| 07/13/1999 | US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders |
| 07/13/1999 | US5922879 N-aminoalkyl-2-anthraquinonecarboxamides: new dopamine receptor subtype specific ligands |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |
| 07/13/1999 | US5922773 Treatment with n-methyl-d-aspartate antagonist for vision defects |
| 07/13/1999 | US5922772 Therapeutic substituted guanidines |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/13/1999 | US5922748 Indole derivatives as 5-HT agonists |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |
| 07/13/1999 | US5922746 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
| 07/13/1999 | US5922741 5-aminopyrazoles useful as tyrosine kinase inhibitors |
| 07/13/1999 | US5922740 Antiinflammatory agents |
| 07/13/1999 | US5922735 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 07/13/1999 | US5922734 Novel compounds for treating psoriasis and methods for their synthesis |
| 07/13/1999 | US5922733 Administering to treat central nervous system disorders such as anxiety, depression, epilepsy, obsessive compulsive disorders, anorexia, bulimia and alzheimer's disease |
| 07/13/1999 | US5922728 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 07/13/1999 | US5922725 Benzimidazole compounds and their use as modulators of the GABAA receptor complex |
| 07/13/1999 | US5922724 Benzimidazole compounds and their use as modulators of the GABA a receptor complex |
| 07/13/1999 | US5922711 Antiallergens, antiinflammatory agents, autoimmune diseases, shock or analgesics |
| 07/13/1999 | US5922701 Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 07/13/1999 | US5922690 Having at least 2 sulfate groups per disaccharide obtained by chemical sulfation of native dermatan sulfate. |
| 07/13/1999 | US5922687 Placing the nucleic acid in an extracellular environment of the cell, defining an enclosure comprising the cell and the extracellular environmenat, establishing an incubation pressure within the enclosure; useful for gene therapy |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922546 Human disintegrin metalloprotease KUZ gene |
| 07/13/1999 | US5922318 Drug protein |
| 07/13/1999 | US5922305 Methods of treating tissues with oxygen-supersaturated emulsions |
| 07/13/1999 | CA1340640C Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6,6-disubstituted-tetrahydropteridines |
| 07/08/1999 | WO1999033979A2 Bone marrow secreted proteins and polynucleotides |
| 07/08/1999 | WO1999033974A1 Serine proteinase inhibitors |
| 07/08/1999 | WO1999033967A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | WO1999033873A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033858A2 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033855A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS |
| 07/08/1999 | WO1999033850A1 NOVEL β-LACTAMASE AND DD-PEPTIDASE INHIBITORS |
| 07/08/1999 | WO1999033849A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | WO1999033841A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 07/08/1999 | WO1999033840A2 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha1-blocking action |
| 07/08/1999 | WO1999033836A1 3'-epimeric k-252a derivatives |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033833A1 Metallocorrinoids as biologically compatible carriers of pharmacological agents |
| 07/08/1999 | WO1999033829A1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
| 07/08/1999 | WO1999033827A1 Novel imidazole derivatives |
| 07/08/1999 | WO1999033815A1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033801A1 Tripeptidyl peptidase inhibitors |
| 07/08/1999 | WO1999033793A2 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | WO1999033789A1 SUBSTITUTED β-ALANINES |
| 07/08/1999 | WO1999033781A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 07/08/1999 | WO1999033485A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | WO1999033484A1 Production process for intravenous immune serum globulin and resultant product |
| 07/08/1999 | WO1999033483A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 07/08/1999 | WO1999033479A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | WO1999033469A1 Benzoxazine compounds for enhancing synaptic response |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | WO1999023109A3 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| 07/08/1999 | WO1999021574A3 Enhancement of morphogen activity |
| 07/08/1999 | WO1999016406A3 Therapeutic method |
| 07/08/1999 | WO1999011606A3 Inhibitors of protein tyrosine phosphatase |
| 07/08/1999 | WO1999011604A9 Sterilized 5-aminolevulinic acid |
| 07/08/1999 | WO1998045711A3 Assay for ligands to tyrosine kinase receptors |
| 07/08/1999 | CA2316545A1 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 07/08/1999 | CA2316444A1 11.beta.-halogen-7.alpha.-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11.beta.-halogen-7.alpha.-substituted estratrienesas well as their use for the production of pharmaceutical agents |
| 07/08/1999 | CA2316385A1 Prodrugs of naaladase inhibitors |
| 07/08/1999 | CA2316235A1 Substituted .beta.-alanines |
| 07/08/1999 | CA2316218A1 Prodrugs of aspartyl protease inhibitors |
| 07/08/1999 | CA2315977A1 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 07/08/1999 | CA2315821A1 Acylphosphates and acylphosphonates as .beta.-lactamase and dd-peptidase inhibitors |
| 07/08/1999 | CA2315790A1 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | CA2282815A1 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |